View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Clinical Trials Week

Susan Hasty, Publisher
Table of Contents . . . August 11th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Multiple Sclerosis - Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis

Myelofibrosis - Cytopia Appoints Study Chairman for JAK2 Clinical Trial

Acid Reflux Disease - Reports from University of Pittsburgh describe recent advances in acid reflux disease

Breast Cancer - New breast cancer research from V. Dieras and co-researchers described

Breast Cancer - Studies from K. Yonemori et al further understanding of breast cancer

Chronic Myeloid Leukemia - Recent findings in chronic myeloid leukemia described by R. Capdeville and colleagues

Colon Cancer - Data on colon cancer described by M. Borner et al

Colon Cancer - Findings from Stanford University advance knowledge in colon cancer

Gastric Cancer - New findings in gastric cancer described from Oita University, Medical Department

Leukemia - New leukemia study findings have been published by scientists at University of Texas

Leukemia Gene Therapy - Study findings from University of Tsukuba provide new insights into leukemia gene therapy

Lung Cancer - New lung cancer study findings have been reported from J.Y. Han et al

Mesothelioma - New research on mesothelioma from G.L. Ceresoli and co-authors summarized

Myeloma - New myeloma research from J.R. Berenson et al outlined

Myeloma - Reports from Keio University, Medical Department describe recent advances in myeloma

Non-Hodgkin Lymphoma - New non-hodgkin lymphoma study findings recently were published by E. Kalinkawarzocha and co-researchers

Ovarian Cancer - Studies in the area of ovarian cancer reported from La Sapienza University

Pharmacokinetics - New pharmacokinetics study findings recently were reported by C.P. Hu and co-researchers

Advaxis, Inc. - Advaxis Incorporated Receives List of Questions from the U.S. Food and Drug Administration

Alzheimer Disease - Allon Therapeutics presents AL-108 human efficacy data at worlds leading Alzheimers disease conference

Alzheimer Disease - Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease

Alzheimer Disease - Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets

Amgen - Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial

ARIAD Pharmaceuticals, Inc. - ARIAD Announces Start of Phase 2 Clinical Trial of Oral Deforolimus in Patients with Metastatic, HER2-Positive Breast Cancer

BioDelivery Sciences International, Inc. - BioDelivery Sciences Initiates Bioral Amphotericin B Clinical Program

BioSante Pharmaceuticals, Inc. - BioSante Featured on TheStreet.com TV

Biosector 2 - Elan, Wyeth present encouraging bapineuzumab Phase 2 trial results at ICAD

Bipolar Disorder - Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)

Cancer Vaccines - NVENTA ANNOUNCES FINAL DATA FROM HSPE7 PHASE 1 CERVICAL DYSPLASIA TRIAL -- Company Provides Update to Phase 2 Development Plan

Chronic Lymphocytic Leukemia - Aegera Initiates a Fifth Phase 1 and 2 Clinical Trial for AEG35156

Clinical Trial Research - Nventa Announces Final Data from HspE7 Phase 1 Cervical Dysplasia Trial

Clinical Trial Research - SemBioSys submits IND for safflower-produced insulin to U.S. FDA

Cornerstone Pharmaceuticals, Inc. - Cornerstone Pharmaceuticals Announces Approval to Conduct Phase I/II Clinical Trial of CPI-613 in Cancer Patients by US FDA

Drug Delivery - Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC

Drug Development - Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities

Drug Development - Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug, Polyphenon E, for the Treatment of CLL

Elan Corporation, plc - Elan Reports Second Quarter 2008 Financial Results

Exelixis, Inc. - Exelixis Notifies GlaxoSmithKline of Proof-of-Concept for XL184

Gene Therapy - Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial

Heart Failure - Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients

Human Genome Sciences, Inc. - Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments

Influenza - BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting

Inspire Pharmaceuticals, Inc. - Inspire Provides Update on Cystic Fibrosis Clinical Program

Introgen Therapeutics, Inc. - ADVEXIN Shows Statistically Significant Six-Month and Overall Survival Benefit as Compared to Methotrexate in Prospectively Defined Biomarker Patient Population

Liver Cancer - Nexavar Approved for Liver Cancer in China

Liver Disease - Intercept Pharmaceuticals Raises $25 Million

Marketing and Licensing Agreements - Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million

Merck & Co., Inc. - ISENTRESS raltegravir, Merck's First in Class Integrase Inhibitor, Suppressed HIV-1 Viral Load and Increased CD4 Cell Counts through 48-Weeks in Treatment-Experienced Adult Patients When Taken wi

Monoclonal Antibodies - Intellect Neurosciences, Inc. Obtains Pivotal European Patent Related To Monoclonal Antibody Passive Immunization Treatment of Alzheimer's Disease

Neose Technologies, Inc. - Neose Technologies Announces GlycoPEG-GCSF Abstract Accepted for Poster Presentation at IXth World Conference on Clinical Pharmacology and Therapeutics

Nuvelo, Inc. - Nuvelo Initiates Phase 1 Clinical Trial of NU206 in Healthy Volunteers

Obesity and Diabetes - Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit

Oncology - Millennium Advances Oncology Pipeline

Patents - OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003

Post Operative Pain - Innocoll Announces Dosing of First Patient in a Third US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain

Pulmonary Fibrosis - InterMune Reports Second Quarter 2008 Financial Results and Business Highlights

QuantRx Biomedical Corporation - QuantRx Biomedical Announces Positive Phase I Safety Results for BFPET, Myocardial Perfusion Imaging MPI Tracer for Positron Emission Tomography PET by FluoroPharma

Quigley Corporation - The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future

RNA Research - Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema

Small Cell Lung Cancer - Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update

Sucampo Pharmaceuticals, Inc. - Sucampo Pharmaceuticals Initiates Phase 2 Trial of Cobiprostone for the Treatment of Portal Hypertension in Patients with Liver Cirrhosis

Zelos Therapeutics, Inc. - Zelos Therapeutics Reaches Agreement with the FDA and EMEA for a Registration Study of ZT-031 for the Treatment of Osteoporosis

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx